Sp253

UNDERSTANDING GUT-BRAIN DYNAMICS IN OBESITY

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

Gathering evidence suggests that communication between the gut and brain plays a major role in health and disease. However, our understanding of the mechanisms underlying gut-brain communication is a major unresolved field of neurogastroenterology. This session will provide major new insights into how ingested contents within the gut wall communicate with extrinsic sensory nerves, that communicate with the brain and how these sensory nerve pathways regulate our health and well being.

Presenter

Speaker Image for Lisa Beutler
Northwestern University

Tracks

Related Products

Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA
Thumbnail for AGA Gut-Brain Communication
AGA Gut-Brain Communication
Gathering evidence suggests that communication between the gut and brain plays a major role in health and disease. However, our understanding of the mechanisms underlying gut-brain communication is a major unresolved field of neurogastroenterology…
Thumbnail for ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…